Overall, icariin, a potential activator of GPER, reduced the levels of ROS and ECM generation in the kidney of diabetic rats, and ameliorated the symptoms of DN through, at least partially, GPER mediated p62-dependent Keap1 degradation and Nrf2 activation. This evidence concerns the gene KEAP1 and liver dysplastic nodule.